Mielcarek, M., Benn, C. L., Franklin, S. A., Smith, D. L., Woodman, B., Marks, P. A., & Bates, G. P. (2011). SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease. Public Library of Science.

Mielcarek, Michal, Caroline L. Benn, Sophie A. Franklin, Donna L. Smith, Ben Woodman, Paul A. Marks, a Gillian P. Bates. SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease. Public Library of Science, 2011.

Mielcarek, Michal, et al. SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease. Public Library of Science, 2011.